Business Description
Kura Oncology is a San Diego-based pharmaceutical company focused on developing new treatments for cancer and other serious diseases. Its first approved drug, KOMZIFTI, targets a specific protein involved in cancer growth and is taken by mouth. The company is also running early-stage trials for darlifarnib, testing it alongside other treatments for patients with solid tumors, while advancing a newer compound called KO-7246 aimed at diabetes and heart-related conditions.
